Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06313632 · ClinicalTrials.gov registry record · Phase 3
Erector Spinae Plane Block With Bupivacaine for Medical Thoracoscopy
A Phase 3 study, sponsored by Icahn School of Medicine at Mount Sinai.
- Terminated
- Registry status
- Phase 3
- Development phase
- 33
- Enrollment target
NCT06313632 is a Phase 3 study that was terminated before completion, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 33 participants.
The verdict
NCT06313632, a Phase 3 study, was terminated before completion, sponsored by Icahn School of Medicine at Mount Sinai.
- TERMINATED
- Registry status
- Phase 3
- Development phase
- 33 participants
- Enrollment target
Study Summary
PlAcebo versus erector spINae pLane block for mEdical ThoracoScopy Study (PAINLESS). This is a prospective triple-blind, randomized controlled trial that evaluates the efficacy of erector spinae plane block (ESPB) with Bupivacaine in reducing pain after medical thoracoscopy (MT) in addition to monitored anesthesia care vs monitored anesthesia care alone.
Interventions
- DRUG Placebo
- DRUG Bupivacaine injection
- OTHER Monitored Anesthesia Care
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 33 participants |
| Start Date | 2024-03-28 |
| Est. Completion | 2025-03-20 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06313632
The ClinicalTrials.gov registry entry for NCT06313632 describes a study currently listed as terminated, categorized as Phase 3. The registered enrollment target is 33 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Icahn School of Medicine at Mount Sinai, which has 708 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT06313632 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06313632 about?
NCT06313632 is a clinical study titled "Erector Spinae Plane Block With Bupivacaine for Medical Thoracoscopy". PlAcebo versus erector spINae pLane block for mEdical ThoracoScopy Study (PAINLESS). This is a prospective triple-blind, randomized controlled trial that evaluates the efficacy of erector spinae plane block (ESPB) with Bupivacaine in reducing pain after medical thoracoscopy (MT) in addition to monit...
What is the current status of trial NCT06313632?
This trial is currently terminated. It is a Phase 3 study. The enrollment target is 33 participants. The study started on 2024-03-28. Estimated completion is 2025-03-20.
What interventions are being tested in trial NCT06313632?
The interventions under investigation include: Placebo (DRUG), Bupivacaine injection (DRUG), Monitored Anesthesia Care (OTHER).
Who is sponsoring clinical trial NCT06313632?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.